The NIH identified 273 drugs in a review of FDA oncologic drug approvals. After applying exclusion criteria, 224 cancer drug approvals across 119 individual drugs were analyzed. Across all tumor types, the median annual cost for a course of an anticancer drug was $196,000 (IQR, $170,000-$277,000). As ASCO begins in Chicago, there will be a lot of PR targeted at Wall Street analysts but minimal discussion about the cost of cancer drugs.

The cost of cancer treatment has skyrocketed in recent years, placing an enormous financial burden on patients, healthcare systems, and society at large. Despite the promises of breakthrough therapies and advanced treatments, the harsh reality is that the pricing of many cancer drugs is not only unsustainable but also often fails to deliver the expected benefits. This situation raises significant concerns about the direction of cancer treatment and the priorities of the pharmaceutical industry.

“A survey from Graphite clearly shows the pharma industry’s challenges as it tries to transition to a digital strategy. “Teams are struggling to measure the impact of digital solutions, limiting the scope for continuous improvement. Problems such as the misalignment of metrics with strategic KPIs, internal data silos, and the late setting of metrics are widespread. The issue of data security and privacy also presents one of the most significant sector-wide barriers to digital innovation.” “A survey from Graphite clearly shows the pharma industry’s challenges as it tries to transition to a digital strategy. “Teams are struggling to measure the impact of digital solutions, limiting the scope for continuous improvement. Problems such as the misalignment of metrics with strategic KPIs, internal data silos, and the late setting of metrics are widespread. The issue of data security and privacy also presents one of the most significant sector-wide barriers to digital innovation.”

The dual challenges of elder care and associated loneliness will become a crisis. These intertwined issues are not just matters of individual well-being but have broad societal implications, from healthcare systems to economic productivity. Understanding and addressing this silent epidemic is crucial for creating a compassionate and sustainable future.

Google is constantly changing its search algorithms, which can make it hard for websites to appear high in search results. A critical strategy for getting noticed by search engines is “topical authority.” This means creating valuable content on specific topics that makes your website a reliable source of information.  Pharma product websites should be a topical authority on the disease states in which they compete.

Starting today, a new rule requires drug commercials to clearly show the potential side effects and when not to take the medicine. This update to a 2007 law gives the FDA more control over drug advertising. Drugmakers have six months to comply with the new rule fully, and it’s unclear how aggressively the FDA will enforce the requirements, per Ropes & Gray. It’s a good step, but a lot more is needed.